← Leaderboards
Jennie Wang
Sri International
$2,583,789
Attributed
$2,583,789
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $560.5K · FY2009–22$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,583,789 · 3
By mechanism
N02$1,313,139 · 2
N01$1,270,650 · 2
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Polly Chang$121,906,628
- Kathryn Baughman$29,412,662
- Toufan Parman$25,866,968
- Deborah Bunin$11,920,896
- Debra Burnin$9,670,591
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsRegulationDrug CandidateMalignant NeoplasmsQuality ControlContractsDrug FormulationsDrug Of AbuseEquipment And Supply InventoriesFormulationReportingAntitumor AgentAntitumor DrugAwardBaseClinical ResearchInstrumentationInvestigational DrugsMonitorNational Institute Of Drug AbuseOpioidPeptide DrugPeptidesPharmacologic Substance
Grant awards (14)
IGF::OT::IGF Synthetic Peptides and Other Drugs of Abuse; Purity Determination, Stability Testing and Quantitative Analysis. NIDA Ref. No. N01DA-18-8945; POP: 09/29/2018 - 09/28/2019. Base Award$416,521
N01 · FY2022 · DA · contact PI
THIS REQUIREMENT IS TO PERFORM THE RELEASE ANALYSIS (APPEARANCE, PMR, IR, HPLC* (ASSAY; IMPURITY), MOISTURE, RESIDUAL SOLVENTS, ROI AND HEAVY METALS)$51,116
N01 · FY2020 · CA · contact PI
ANALYSIS OF THE FOLLOWING: APPEARANCE, PROTON NMR, INFRARED, HPLC (ASSAY, IMPURITY), RESIDUAL SOLVENTS, MOISTURE (KF), RESIDUE ON IGNITION, HEAVY META$26,444
N01 · FY2020 · CA · contact PI
IGF::OT::IGF Synthetic Peptides and Other Drugs of Abuse; Purity Determination, Stability Testing and Quantitative Analysis. NIDA Ref. No. N01DA-18-8945; POP: 09/29/2018 - 09/28/2019. Base Award$376,192
N01 · FY2019 · DA · contact PI
ANALYSIS OF ANTI-CANCER CHEMICAL & PHARMACEUTICAL FORMULATIONS PRB$25,858
N02 · FY2019 · CA · contact PI
Analysis of Bulk Drug Lot NSC 777586$24,886
N01 · FY2019 · CA · contact PI
IGF::OT::IGF Synthetic Peptides and Other Drugs of Abuse; Purity Determination, Stability Testing and Quantitative Analysis. NIDA Ref. No. N01DA-18-8945; POP: 09/29/2018 - 09/28/2019. Base Award$375,491
N01 · FY2018 · DA · contact PI
STABILITY STUDY OF NSC 777586 (AZA-T-DCYD)$32,227
N02 · FY2018 · CA · contact PI
NExT FdCyd_THU NSC112907 (CT029-402-448-003), TO#3 Milestone 2 - THU bulk drug analysis, DTP-18-026, HHSN261201700014I, Analysis of Anti-Cancer Chemical & Pharmaceutical Formulations PRB$23,454
N02 · FY2018 · CA · contact PI
IGF::OT::IGF Admin Costs - Contract Orientation & Kick Off Mtg, DTP-17-039, 08/01/17 - 09/30/17, HHSN261201700014I, Analysis of Anti-Cancer Chemical & Pharmaceutical Formulations PRB$895
N02 · FY2017 · CA · contact PI
Analysis of Anti-Cancer Chemicals and Pharmaceuctical Formulations$80,400
N02 · FY2012 · CA · contact PI
Analysis of Anti-Cancer Chemicals and Pharmaceuctical Formulations$560,521
N02 · FY2011 · CA · contact PI
Analysis of Anti-Cancer Chemicals and Pharmaceuctical Formulations$200,000
N02 · FY2010 · CA · contact PI
Analysis of Anti-Cancer Chemicals and Pharmaceuctical Formulations$389,784
N02 · FY2009 · CA · contact PI